Diseases /

Leptomeningeal Melanoma

Overview

Clinical Trials

There
is 1 clinical trial
for leptomeningeal melanoma, of which 1
is
open and 0
are
completed or closed.
Of the
trial that contains
leptomeningeal melanoma as an inclusion criterion, 1 is phase 2 (1 open).

Adoptive cell therapy agent and interleukin-2
are the most common
interventions in
leptomeningeal melanoma clinical trials.

Drugs Being Investigated in Leptomeningeal Melanoma Trials by Recruiting Status

Disease Details

Synonyms

Melanoma of Leptomeninges, Melanoma of the Leptomeninges, Meningeal Melanoma

Parent(s)

Meningeal Melanoma

References

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.